Target intelligence / Profile preview

RNA, U6 small nuclear 796, pseudogene (RNU6-796P)

Target
RNU6-796P
Molecular classification
Other
01

Overview

RNU6-796P is a member of the U6 small nuclear RNA pseudogene family. Pseudogenes like RNU6-796P are DNA sequences that resemble functional genes but lack the ability to encode functional proteins or RNAs due to mutations, deletions, or insertions. U6 small nuclear RNAs are components of the spliceosome, crucial for mRNA splicing, but pseudogenes of U6 like RNU6-796P are considered non-functional remnants in the genome[1][4][7]. Most U6 pseudogenes do not produce functional RNA and have no established biological role, therapeutic value, or disease association specific to their sequence. In rare contexts, pseudogenes may regulate gene expression through various RNA-mediated regulatory mechanisms, but there is no evidence for RNU6-796P having such activity[2][7]. Key points: - RNU6-796P is a non-coding RNA pseudogene, not a protein or functional RNA[1][4]. - It is not considered a therapeutic drug target; there are no drugs, biomarkers, or clinical safety considerations associated with it[1][4]. - The name is accurate and standardized in current gene databases, but as a pseudogene, it does **not** fulfill the requirements of a classical drug/receptor/enzyme target[1][4]. - The only relevant molecular classification is "Other" (pseudogene)[1][4]. - No alias beyond RNU6-796P and its descriptive name. - No specific biological function, disease linkage, or pharmacological relevance applies to RNU6-796P[1][4][2].

Other names
RNU6-796PU6 small nuclear RNA pseudogene 796
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on RNA, U6 small nuclear 796, pseudogene (RNU6-796P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 796, pseudogene (RNU6-796P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call